- Home
- SNTI vs DWSN Comparison
SNTI vs DWSN Comparison
Compare SNTI & DWSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- DWSN
- Stock Information
- Founded
- SNTI 2016
- DWSN 1952
- Country
- SNTI United States
- DWSN United States
- Employees
- SNTI N/A
- DWSN N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- DWSN Oil & Gas Production
- Sector
- SNTI Health Care
- DWSN Energy
- Exchange
- SNTI Nasdaq
- DWSN Nasdaq
- Market Cap
- SNTI 53.6M
- DWSN 58.4M
- IPO Year
- SNTI N/A
- DWSN N/A
- Fundamental
- Price
- SNTI $2.15
- DWSN $2.03
- Analyst Decision
- SNTI Strong Buy
- DWSN
- Analyst Count
- SNTI 3
- DWSN 0
- Target Price
- SNTI $9.67
- DWSN N/A
- AVG Volume (30 Days)
- SNTI 327.7K
- DWSN 81.6K
- Earning Date
- SNTI 11-13-2025
- DWSN 11-12-2025
- Dividend Yield
- SNTI N/A
- DWSN N/A
- EPS Growth
- SNTI N/A
- DWSN N/A
- EPS
- SNTI N/A
- DWSN N/A
- Revenue
- SNTI N/A
- DWSN $55,987,000.00
- Revenue This Year
- SNTI N/A
- DWSN N/A
- Revenue Next Year
- SNTI $150.00
- DWSN N/A
- P/E Ratio
- SNTI N/A
- DWSN N/A
- Revenue Growth
- SNTI N/A
- DWSN N/A
- 52 Week Low
- SNTI $1.26
- DWSN $1.08
- 52 Week High
- SNTI $16.94
- DWSN $5.54
- Technical
- Relative Strength Index (RSI)
- SNTI 62.17
- DWSN 54.80
- Support Level
- SNTI $1.92
- DWSN $2.02
- Resistance Level
- SNTI $2.29
- DWSN $2.35
- Average True Range (ATR)
- SNTI 0.25
- DWSN 0.16
- MACD
- SNTI 0.01
- DWSN 0.01
- Stochastic Oscillator
- SNTI 55.06
- DWSN 51.46
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About DWSN Dawson Geophysical Company
Dawson Geophysical Co is a provider of onshore seismic data acquisition services with operations throughout the continental United States and Canada. The company acquires and processes 2 D, 3 D, and multi-component seismic data for clients, ranging from oil and gas companies to independent oil and gas operators for use in the onshore drilling and production of oil and natural gas as well as provides multi-client data libraries. It operates through a single segment being Contract seismic data acquisition and processing services. In addition, the company provides multi-component seismic data surveys which involve the recording of alternative seismic waves. Geographically, it generates maximum revenue from the United States.